Free Trial

Anson Funds Management LP Acquires New Position in Cameco Co. (NYSE:CCJ)

Cameco logo with Basic Materials background

Anson Funds Management LP acquired a new position in shares of Cameco Co. (NYSE:CCJ - Free Report) TSE: CCO in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 10,000 shares of the basic materials company's stock, valued at approximately $514,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Sierra Ocean LLC acquired a new position in Cameco in the fourth quarter worth $25,000. Hurley Capital LLC purchased a new stake in shares of Cameco during the fourth quarter valued at $27,000. Bank Julius Baer & Co. Ltd Zurich purchased a new stake in shares of Cameco in the 4th quarter valued at approximately $28,000. Whipplewood Advisors LLC acquired a new position in shares of Cameco in the 4th quarter valued at about $33,000. Finally, Compass Planning Associates Inc acquired a new stake in Cameco during the fourth quarter valued at $36,000. Hedge funds and other institutional investors own 70.21% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on CCJ shares. Stifel Nicolaus assumed coverage on Cameco in a research report on Wednesday, March 12th. They issued a "buy" rating for the company. Stifel Canada upgraded Cameco to a "strong-buy" rating in a research report on Wednesday, March 12th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $90.00 price objective on shares of Cameco in a research note on Tuesday, March 4th. Glj Research lifted their price target on Cameco from $62.76 to $75.68 and gave the company a "buy" rating in a report on Wednesday, March 12th. Finally, Sanford C. Bernstein initiated coverage on Cameco in a research note on Tuesday, April 1st. They issued an "outperform" rating and a $52.00 target price for the company. One research analyst has rated the stock with a sell rating, nine have given a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $70.03.

View Our Latest Report on Cameco

Cameco Stock Down 0.3 %

NYSE:CCJ traded down $0.13 on Thursday, hitting $49.61. The stock had a trading volume of 2,739,854 shares, compared to its average volume of 4,059,500. Cameco Co. has a 1 year low of $35.00 and a 1 year high of $62.55. The firm's fifty day simple moving average is $42.39 and its two-hundred day simple moving average is $49.07. The stock has a market cap of $21.60 billion, a P/E ratio of 177.18 and a beta of 0.89. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.26 and a current ratio of 2.88.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last released its earnings results on Thursday, May 1st. The basic materials company reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.18 by ($0.07). Cameco had a net margin of 5.39% and a return on equity of 4.34%. The company had revenue of $549.58 million for the quarter, compared to the consensus estimate of $890.07 million. During the same period in the prior year, the company earned $0.13 earnings per share. The firm's revenue was up 24.4% on a year-over-year basis. Analysts predict that Cameco Co. will post 1.27 earnings per share for the current year.

About Cameco

(Free Report)

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.

Featured Articles

Institutional Ownership by Quarter for Cameco (NYSE:CCJ)

Should You Invest $1,000 in Cameco Right Now?

Before you consider Cameco, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.

While Cameco currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines